Group 1 - The company, Ningbo Xingyuan Zhuomai Technology Co., Ltd., has received an inquiry letter from the Shenzhen Stock Exchange regarding its application to issue convertible bonds to unspecified objects [1][2] - The company has updated its application documents, including financial data, in response to the inquiry letter and has disclosed these updates on the Giant Tide Information Network [2] - The issuance of convertible bonds is subject to approval from the Shenzhen Stock Exchange and the China Securities Regulatory Commission, with uncertainties regarding the approval timeline [2] Group 2 - The company assures that the information disclosed is true, accurate, and complete, with no false records or misleading statements [1] - The company will continue to fulfill its information disclosure obligations in accordance with relevant regulations as the situation progresses [2]

证券代码：603037 证券简称：凯众股份 公告编号：2025-034 上海凯众材料科技股份有限公司 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 一、董事会会议召开情况 上海凯众材料科技股份有限公司（以下简称"公司"）第四届董事会第二十五 次会议于 2025 年 8 月 12 日（星期二）在上海市浦东新区建业路 813 号公司会议 室以现场结合通讯的方式召开。本次会议应出席董事 9 人，实际出席董事 9 人。 会议由董事长杨建刚先生主持，监事、部分高管列席。会议召开符合有关法 律、法规、规章和《公司章程》的规定。经各位董事认真审议，会议形成了如下 决议： 二、董事会会议审议情况 （一）审议通过《关于进一步明确公司向不特定对象发行可转换公司债券方 案的议案》 公司已收到中国证券监督管理委员会出具的《关于同意上海凯众材料科技 股份有限公司向不特定对象发行可转换公司债券注册的批复》（证监许可 [2025]1244 号），同意公司向不特定对象发行可转换公司债券（以下简称"本次 发行"）的注册申请。公司董事会根据 2023 年年度股 ...

Group 1 - The company announced adjustments to its plan for issuing convertible bonds to unspecified objects, including changes to the total amount of funds to be raised and their intended use [1][2][3] - The total amount of the convertible bonds to be issued has been revised from a maximum of RMB 886 million to a maximum of RMB 872 million [2][3] - The intended use of the raised funds has been detailed, with the total investment amount for projects being RMB 911.2762 million, and the adjusted amount for the bond issuance being RMB 872 million [3][4] Group 2 - The company held multiple board meetings to review and approve the revised bond issuance plan, with the latest meeting occurring on August 8, 2025 [2][5] - The adjustments made to the bond issuance plan include revisions to the fundraising scale and the allocation of funds, which have been disclosed on the Shanghai Stock Exchange website [4][6] - The company emphasized that the bond issuance plan is subject to approval by the shareholders' meeting and regulatory authorities, including the China Securities Regulatory Commission [5][6]

Meeting Overview - The 19th meeting of the 5th Supervisory Board of Jiangxi Sanxin Medical Technology Co., Ltd. was held on August 7, 2025, in compliance with relevant laws and regulations [1][2]. Financial Reporting - The Supervisory Board approved the company's 2025 semi-annual report, confirming that the report accurately reflects the company's actual situation without any false records or omissions [1][3]. Profit Distribution Plan - The company proposed a mid-term profit distribution plan, which includes a cash dividend of 1 yuan (including tax) for every 10 shares based on a total of 522,237,525 shares, after deducting 160,000 shares held in the repurchase account [2][3]. Stock Incentive Plan - The Supervisory Board approved the achievement of conditions for the first unlock period of the 2024 restricted stock incentive plan, allowing 112 eligible participants to unlock a total of 3,849,575 shares [3][4]. Convertible Bond Issuance - The company confirmed its eligibility to issue convertible bonds to unspecified investors, with a total fundraising target of up to 530 million yuan [5][6]. - The convertible bonds will be issued at face value, with a term of six years and an annual interest payment structure [6][7]. Fund Utilization - The proceeds from the bond issuance will be allocated to projects including the expansion of blood dialysis membrane production and the construction of high-performance blood purification equipment production lines, totaling 530 million yuan [17][18]. Governance and Compliance - The company established rules for the bondholders' meeting and outlined measures to mitigate the dilution of immediate returns for existing shareholders due to the bond issuance [21][22].

Core Viewpoint - Suzhou TZTEK Technology Co., Ltd. plans to issue convertible bonds to unspecified investors, with a total amount not exceeding RMB 872 million, to support its business operations and growth [4][18]. Summary by Sections Issuer and Legal Compliance - The company and its board guarantee the truthfulness and completeness of the announcement, and the issuance complies with relevant laws and regulations regarding the issuance of securities on the Sci-Tech Innovation Board [1][4]. Issuance Overview - The type of securities to be issued is convertible bonds, which can be converted into A-shares of the company. The bonds will be listed on the Shanghai Stock Exchange's Sci-Tech Innovation Board [4][5]. - The total issuance amount is capped at RMB 872 million, with each bond having a face value of RMB 100 [4][5]. Bond Terms - The bonds will have a term of 6 years from the date of issuance [5]. - The interest rate will be determined by the board based on market conditions and company specifics, with annual interest payments [5][6]. - The conversion period for the bonds will start six months after issuance and last until maturity [7]. Conversion and Redemption - The initial conversion price will be set based on the average stock price over the 20 trading days prior to the announcement, with adjustments possible under certain conditions [7][8]. - The company has the right to redeem the bonds under specific conditions, such as if the stock price exceeds 120% of the conversion price for a certain period [11]. Financial Information - The company’s financial reports for the years 2022, 2023, and 2024 have been audited, showing a total asset value of RMB 360.41 million as of March 31, 2025 [20][21]. - The total revenue for the first quarter of 2025 is reported at RMB 21.86 million, with total costs of RMB 27.07 million [21]. Use of Proceeds - The proceeds from the bond issuance will be used for specific projects, with a total investment amount of RMB 911.28 million planned, and the company will self-fund any shortfall if necessary [18][19]. Bondholder Rights and Obligations - Bondholders will have rights to interest payments, conversion to shares, and the ability to sell back the bonds under certain conditions [14][15]. - They are also obligated to comply with the terms of the bond issuance and pay the subscription amount [15][16]. Meeting and Governance - The company will convene bondholder meetings under specific circumstances, such as changes to the bond terms or financial difficulties [16][17]. Duration of the Issuance Plan - The validity of the bond issuance plan is set for 12 months from the date of approval by the shareholders' meeting [19].

Core Viewpoint - Jiangxi Sanxin Medical Technology Co., Ltd. plans to issue convertible bonds to enhance capital strength and profitability, with a total fundraising amount not exceeding 530 million yuan [2][11][30] Group 1: Necessity of the Issuance - The issuance of convertible bonds is necessary to improve the company's core competitiveness and sustainable development capabilities [3][4] - The projects funded by the issuance have been carefully evaluated and are expected to enhance the company's operational capacity [3][12] Group 2: Use of Proceeds - The net proceeds from the issuance will be used for the expansion of blood dialysis membrane and blood dialysis device production, as well as for the development of high-performance blood purification equipment [2][30] - The funds will also be allocated to the renovation of the electronic accelerator sterilization production line and to supplement working capital [2][30] Group 3: Issuance Object and Method - The issuance will target unspecified investors, including natural persons, legal entities, and qualified institutional investors [4][5] - Original shareholders will have priority in the allocation of the convertible bonds, with specific ratios to be determined by the board of directors [5][6] Group 4: Pricing and Adjustment Mechanism - The initial conversion price of the bonds will be based on the average stock price over the previous 20 trading days and the last trading day before the announcement [6][9] - The conversion price will be adjusted in case of stock dividends, new share issuance, or cash dividends [7][8] Group 5: Financial Health and Compliance - The company has maintained a stable financial condition, with asset-liability ratios of 35.33%, 34.31%, and 36.62% for the years 2022, 2023, and 2024 respectively [15][16] - The average distributable profit over the last three years is sufficient to cover the interest on the bonds, ensuring compliance with regulatory requirements [11][12] Group 6: Fairness and Reasonableness of the Issuance - The issuance plan has been thoroughly reviewed by the board and is deemed beneficial for the company's strategic goals and shareholder interests [31][32] - Measures will be taken to mitigate the potential dilution of immediate returns for shareholders [31]

证券代码：688798 证券简称：艾为电子 上海艾为电子技术股份有限公司 2025 年第一次临时股东大会会议资料 上海艾为电子技术股份有限公司 Shanghai Awinic Technology Co., Ltd. 二〇二五年八月 上海艾为电子技术股份有限公司 2025 年第一次临时股东大会会议 资料 议案四：关于公司向不特定对象发行可转换公司债券方案论证分析报告的议案 ........ 20 议案五：关于公司向不特定对象发行可转换公司债券募集资金使用可行性分析报告的议案 议案六：关于公司截至 2025 年 6 月 30 日止前次募集资金使用情况报告的议案 ........ 22 议案七：关于公司向不特定对象发行可转换公司债券摊薄即期回报、采取填补措施及相关主 议案十一：关于提请股东大会授权董事会及其授权人士全权办理本次向不特定对象发行可转 上海艾为电子技术股份有限公司 2025 年第一次临时股东大会会议资料 上海艾为电子技术股份有限公司 为维护全体股东的合法权益，确保股东大会的正常秩序和议事效率，保证大 会的顺利进行，根据《中华人民共和国公司法》（以下简称"《公司法》"）、 《中华人民共和国证券法》（以下 ...

Meeting Overview - The second meeting of the board of directors of Jiangsu Weidao Nano Technology Co., Ltd. was held on August 1, 2025, with all six directors present, ensuring compliance with relevant laws and regulations [1][2]. Key Resolutions - The board approved the proposal for issuing convertible bonds to unspecified objects, having received approval from the China Securities Regulatory Commission [1][3]. - The total amount of the proposed convertible bonds is RMB 1,170 million, with an issuance of 1,170,000 hands (11,700,000 pieces) [3][12]. - Each bond will have a face value of RMB 100 and will be issued at par [3][12]. - The bonds will have a term of six years, from August 6, 2025, to August 5, 2031 [3][12]. - The coupon rates are set at 0.20% for the first year, 0.40% for the second year, and will be determined for subsequent years [3][12]. Bond Conversion and Interest Payment - The bonds will pay interest annually, with the first payment occurring five trading days after the interest payment date [4][5]. - The initial conversion price is set at RMB 33.57 per share, based on the average trading price of the company's stock over the previous twenty trading days [6][12]. - The conversion period will start six months after the issuance and last until the bond maturity date [5][9]. Redemption and Buyback Provisions - Upon maturity, the company will redeem the bonds at face value plus any accrued interest [10][11]. - The company has the right to redeem the bonds if the stock price exceeds 130% of the conversion price for a specified period or if the unconverted bond balance is below RMB 30 million [10][11]. Shareholder Rights and Fund Management - Shareholders will have the right to participate in the bond issuance, with priority given to existing shareholders on the registration date [13][14]. - The company will establish a special account for the funds raised from the bond issuance and will sign a fund supervision agreement [16][17]. - The company’s credit rating for the bonds is AA, as assessed by a credit rating agency [12][19]. Capital Changes - The company’s registered capital will increase from RMB 457,678,129 to RMB 461,157,283 following the completion of a stock incentive plan [18][19].

Core Points - Jiangsu Weidao Nano Technology Co., Ltd. is issuing convertible bonds to unspecified investors, having received approval from the China Securities Regulatory Commission [1] - The bonds will be preferentially allocated to existing shareholders, with any remaining bonds available to the public through the Shanghai Stock Exchange [1] - A roadshow will be held on August 5, 2025, to inform investors about the bond issuance [2] Group 1 - The company has obtained regulatory approval for the issuance of convertible bonds [1] - The issuance will prioritize existing shareholders before offering remaining bonds to the public [1] - The roadshow aims to provide details about the bond issuance and will feature key management and underwriting personnel [2]

Core Viewpoint - The company plans to issue convertible bonds to unspecified investors, with a total amount not exceeding RMB 577.89 million, to support its operational and investment needs [2][16][20]. Board Meeting Details - The board meeting was held both in person and via communication, with all members present [1]. - The board approved the proposal for issuing convertible bonds, with a unanimous vote of 7 in favor [2][3]. Convertible Bond Issuance Plan - The type of securities to be issued is convertible bonds that can be converted into A-shares listed on the Shenzhen Stock Exchange [2]. - The total amount of funds to be raised through this issuance is capped at RMB 577.89 million [2][16]. - Each bond will have a face value of RMB 100 and will be issued at face value [3]. - The bonds will have a term of six years from the date of issuance [3]. - The interest rate will be determined based on market conditions and company specifics, with adjustments possible if bank deposit rates change [3][4]. Interest Payment and Redemption - Interest will be paid annually, with the principal repaid at maturity [4][5]. - The bondholders will have the option to convert their bonds into shares after a six-month period from issuance [5]. - The initial conversion price will be determined based on the average stock price prior to the announcement [5][6]. Rights and Obligations of Bondholders - Bondholders will have rights to interest payments, conversion into shares, and the ability to sell back the bonds under certain conditions [12][13]. - The company will not provide guarantees for the bonds [18]. Use of Proceeds - The proceeds from the bond issuance will be primarily used for the MIM components and assembly production project, with a total investment of RMB 588.42 million [17]. - If the actual funds raised are less than planned, the company will use its own funds to cover the shortfall [17]. Management of Funds - The raised funds will be managed in a dedicated account, with specific protocols established for their use [18]. Shareholder Rights - Existing shareholders will have priority in the bond issuance, with specific proportions to be determined [15][26]. Future Plans - The company aims to enhance its governance structure by increasing the board size from 7 to 9 members, including a non-independent director and a representative from employees [30][31].